Regeneron Announces Upcoming 2013 Investor Conference Presentation

TARRYTOWN, N.Y., Dec. 4, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast its presentation at the Oppenheimer 24th Annual Healthcare Conference on Wednesday, December 11, 2013.  The presentation is scheduled for 10:05 a.m. Eastern Time and may be accessed through the Company's web site,, on the 'Events and Presentations' page.  An archived version of the presentation will be available for 30 days.

About Regeneron Pharmaceuticals
Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.  Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, asthma, and atopic dermatitis.  For additional information about the company, please visit

Contact Information:

Manisha Narasimhan, Ph.D.

Peter Dworkin

Investor Relations

Corporate Communications                           



SOURCE Regeneron Pharmaceuticals, Inc.


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.


PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.